Orbimed Advisors - PANDION THERAPEUTICS INC ownership

PANDION THERAPEUTICS INC's ticker is PAND and the CUSIP is 698340106. A total of 76 filers reported holding PANDION THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of PANDION THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$31,720,000
+44.2%
528,229
-64.3%
0.30%
+54.7%
Q4 2020$21,992,000
+29.6%
1,480,9400.0%0.19%
-9.9%
Q3 2020$16,972,0001,480,9400.21%
Other shareholders
PANDION THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Versor Investments LP 743,432$44,643,0002.66%
Chicago Capital Management, LLC 65,636$3,938,0001.83%
NEXPOINT ASSET MANAGEMENT, L.P. 110,912$6,660,0001.74%
ALPINE ASSOCIATES MANAGEMENT INC. 521,900$31,340,0000.85%
BCK CAPITAL MANAGEMENT LP 15,000$901,0000.50%
Magnetar Financial LLC 724,177$43,487,0000.42%
WATER ISLAND CAPITAL LLC 94,934$5,701,0000.35%
Orbimed Advisors 528,229$31,720,0000.30%
GARDNER LEWIS ASSET MANAGEMENT L P 25,000$1,501,0000.27%
FEDERATED HERMES, INC. 1,049,240$63,007,0000.12%
View complete list of PANDION THERAPEUTICS INC shareholders